| Ytd | -17.43% | |
| 1y | -36.29% |
| Open | 18.99 | Prev Close | 18.74 | Low | 18.34 | High | 19.19 | Mkt Cap | 469.07M |
| Vol | 19.10K | Avg Vol | 149.89K | EPS | 1.17 | P/E | 15.79 | Forward P/E | 31.46 |
| Beta | 1.35 | Short Ratio | 0.99 | Inst. Own | 46.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 18.13 | 200-d Avg | 20.84 | 1yr Est | 58.75 |
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”) announce
Docebo NASDAQ: DCBO is seeing improved enterprise demand after addressing product and go-to-market g
Docebo Inc. (DCBO:CA) Q1 2026 Earnings Call Transcript
Docebo NASDAQ: DCBO used its Q1 2026 earnings call primarily to discuss demand trends and customer i
Although the revenue and EPS for Docebo (DCBO) give a sense of how its business performed in the qua
Docebo Inc. (DCBO) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus
Docebo (NASDAQ:DCBO) affirms FY2026 sales outlook from $271.000 million-$273.000 million to $271.000
Docebo (NASDAQ:DCBO) reported quarterly earnings of $0.34 per share which met the analyst consensus
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) (“Docebo” or the “Company”), the Ente
Docebo (DCBO) is well positioned to outperform the market, as it exhibits above-average growth in fi
Docebo (DCBO) saw its shares surge in the last session with trading volume being higher than average
Docebo (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings
Docebo is repositioning toward larger enterprise clients, enhancing retention and ARR per client, an
Docebo Inc. (DCBO) shares have started gaining and might continue moving higher in the near term, as
Docebo (DCBO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about t
The average of price targets set by Wall Street analysts indicates a potential upside of 59.4% in Do
After reaching an important support level, Docebo Inc. (DCBO) could be a good stock pick from a tech
Cantor Fitzgerald analyst Matthew Vanvliet reiterates Docebo (NASDAQ:DCBO) with a Overweight and
Docebo Inc. (DCBO:CA) Q4 2025 Earnings Call Transcript
Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), the Enterprise Platform for the AI-era workforce, unifying sk
MIAMI--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), (“Docebo” or the “Company”), the ente
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), the Enterprise Platform for the AI-
On April 20, 2026, Docebo Inc (DCBO) shares rose 3.3% today, trading at $17.28. The stock has experi
TORONTO--(BUSINESS WIRE)--Docebo Inc. (Nasdaq: DCBO; TSX: DCBO), a leading AI workforce readiness pl
Scotiabank analyst Kevin Krishnaratne maintains Docebo (NASDAQ:DCBO) with a Sector Outperform and
Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:DCBO) with a Equal-Weight and lowers th
Needham analyst Ryan MacDonald maintains Docebo (NASDAQ:DCBO) with a Buy and lowers the price tar
Docebo (NASDAQ:DCBO) reported quarterly earnings of $0.45 per share which beat the analyst consensus
Scotiabank analyst Kevin Krishnaratne maintains Docebo (NASDAQ:DCBO) with a Sector Outperform and
Alphabet Inc's (NASDAQ:GOOG) Google is quietly launching on demand practice exams for standardiz
Cantor Fitzgerald analyst Matthew Vanvliet maintains Docebo (NASDAQ:DCBO) with a Overweight and l
Cantor Fitzgerald analyst Matt VanVliet assumes Docebo (NASDAQ:DCBO) with a Overweight rating and
Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:DCBO) with a Equal-Weight and lowers th
Needham analyst Ryan MacDonald maintains Docebo (NASDAQ:DCBO) with a Buy and lowers the price tar
Docebo (NASDAQ:DCBO) raises FY2025 sales outlook from $238.624 million-$240.793 million to $241.661
Docebo (NASDAQ:DCBO) reported quarterly earnings of $0.34 per share which beat the analyst consensus
Oppenheimer analyst Ken Wong initiates coverage on Docebo (NASDAQ:DCBO) with a Outperform rating
CIBC analyst Stephanie Price maintains Docebo (NASDAQ:DCBO) with a Outperformer and lowers the pr
Affirm, AvePoint, and Docebo rank in the bottom 10% for value this week—see their percentile drop an